Search

The article summarizes the activity concentrations data of 226 Ra and the sum of uranium isotopes (∑U) in samples of drinking underground water for different regions of Ukraine studied during 1998-2023 in the radiation monitoring laboratory of the State Institution "O.M. Marzieiev Institute of Public Health National Academy of Medical Sciences of Ukraine. Arithmetic mean and standard deviations, minimum and maximum values for 226 Ra and ∑U activity concentrations are presented for the entire 1240 sample set and for each region separately. Collected data show that the established state permissible level for drinking water of 1.0 Bq/l is exceeded for 226 Ra in 1.1% of the studied samples, and for ∑U-in 3.9% correspondingly. The detected high levels of 226 Ra and ∑U activity concentrations correspond to certain regions belonging to the Ukrainian crystalline shield territory. A comparison of the current data with the data of previous studies held during of 1989-1991 indicates a significant difference: for the previous studies the average and standard deviations are much higher. We attribute this to the fact that the centralized sampling of previous studies was random, and it was related exclusively to communal water supply systems. At the same time, the current sample set covers a much larger number of regions, different water consumers; the data set includes the results of repeated studies for a large number of sources, in particular, sources with purified water. Hypothetical exposure doses caused by consumption of 226 Ra and ∑U in water for the current sample set were estimated for different age groups for each sample studied, as is, without taking into account the pattern of water consumption. The corresponding dose exceeds the WHO recommended value of 0.1 mSv per year for children under the age of one year for 220 cases (17.7%). This dose limit excess for other age groups corresponds-for children: aged 12-17 years-13.1%, aged 1-2 years-7.4%, 7-12 years old-5.6%, 2-7 years old-3.9% and for adults-4.1%., (© 2024. The Author(s).)

Background: Most public cord blood (CB) banks currently discard more than 80% of umbilical CB units not suitable for hemopoietic stem cell transplant due to low stem cell count. Although CB platelets, plasma, and red blood cells have been used for experimental allogeneic applications in wound healing, corneal ulcer treatment, and neonatal transfusion, no standard procedures for their preparation have been defined internationally., Materials and Methods: A network of 12 public CB banks in Spain, Italy, Greece, the UK, and Singapore developed a protocol to validate a procedure for the routine production of CB platelet concentrate (CB-PC), CB platelet-poor plasma (CB-PPP), and CB leukoreduced red blood cells (CB-LR-RBC) using locally available equipment and the commercial BioNest ABC and EF medical devices. CB units with >50 mL volume (excluding anticoagulant) and ≥150×10 9 /L platelets were double centrifuged to obtain CB-PC, CB-PPP, and CB-RBC. The CB-RBC were diluted with saline-adenine-glucose-mannitol (SAGM), leukoreduced by filtration, stored at 2-6°C, and tested for hemolysis and potassium (K+) release over 15 days, with gamma irradiation performed on day 14. A set of acceptance criteria was pre-defined. This was for CB-PC: volume ≥5 mL and platelet count 800-1,200×10 9 /L; for CB-PPP: platelet count <50×10 9 /L; and for CB-LR-RBC: volume ≥20 mL, hematocrit 55-65%, residual leukocytes <0.2×10 6 /unit, and hemolysis ≤0.8%., Results: Eight CB banks completed the validation exercise. Compliance with acceptance criteria was 99% for minimum volume and 86.1% for platelet count in CB-PC, and 90% for platelet count in CB-PPP. Compliance in CB-LR-RBC was 85.7% for minimum volume, 98.9% for residual leukocytes, and 90% for hematocrit. Compliance for hemolysis ≤0.8% decreased from 89.0 to 63.2% from day 0 to 15. K+ release increased from 3.0±1.8 to 25.0±7.0 mmol/L from day 0 to 15, respectively., Discussion: The MultiCord12 protocol was a useful tool to develop preliminary standardization of CB-PC, CB-PPP, and CB-LR-RBC.